Can Thought Field Therapy (TFT) be Helpful for Patients With an Anxiety Disorder?

NCT ID: NCT00202709

Last Updated: 2011-07-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

52 participants

Study Classification

INTERVENTIONAL

Study Start Date

2002-05-31

Study Completion Date

2003-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to find out if Thought Field Therapy has effect on certain anxiety disorders; agoraphobia, social phobia, and post traumatic stress disorder (PTSD).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Thought Field Therapy is an alternative treatment method that has been shown, by casuistic reports, to give good results when applied for anxiety disorders. In this study 52 patients, with one or more of the diagnoses agoraphobia, social phobia and/or PTSD, where randomized to either treatment with TFT or a wait list. The treatment group all got treatment in one week. 2 1/2 months later both the treatment group and the control group were tested on the same items as before the treatment started. After this evaluation phase the control group got the same treatment as the treatment or study group. Both groups were evaluated 3 and 12 months after treatment, the study group also 6 months after treatment. 4 patients were omitted because they changed groups. The study were performed from May 2002 until June 2003.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Agoraphobia Social Phobia PTSD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Thought Field Therapy (TFT)

Treatment with TFT, first one hour, then 1/2 hour.

Group Type EXPERIMENTAL

Thought Field Therapy (TFT)

Intervention Type BEHAVIORAL

Treatment with TFT twice in one week

Wait list control

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Thought Field Therapy (TFT)

Treatment with TFT twice in one week

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Wait list control

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* One or more of the study diagnoses agoraphobia, social phobia and/or PTSD

Exclusion Criteria

* Ongoing psychosis
* Ongoing serious drug problems
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sorlandet Hospital HF

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sorlandet sykehus HF

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Audun C Irgens, MD

Role: PRINCIPAL_INVESTIGATOR

Sorlandet Hospital HF

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sorlandet Hospital

Arendal, , Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

References

Explore related publications, articles, or registry entries linked to this study.

Irgens A, Dammen T, Nysaeter TE, Hoffart A. Thought Field Therapy (TFT) as a treatment for anxiety symptoms: a randomized controlled trial. Explore (NY). 2012 Nov-Dec;8(6):331-8. doi: 10.1016/j.explore.2012.08.002.

Reference Type DERIVED
PMID: 23141789 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SSHF-AUIR-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Effect of Dual Attention in an EMDR Intervention
NCT05600868 ENROLLING_BY_INVITATION NA